AI assistant
Sending…
SynAct Pharma — Major Shareholding Notification 2023
Jun 19, 2023
3114_iss_2023-06-19_2d770c97-a678-4da2-b7ca-58b24bd31e3e.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer SynAct Pharma AB
Holder
Thomas Jonassen
Instrument
| Instrument | Ordinary SE0008241491 |
|---|---|
| Before the transaction | |
| Shares | 4,923,421 |
| Voting rights | 4,923,421 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 16/06/2023 |
| Limit for number of shares | 15 % |
| Limit for number of votes | 15 % |
| After the transaction | |
| Quantity | |
| Shares | 4,693,421 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 4,693,421 |
| Percentage | |
| Directly held shares | 14.74946 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 14.74946 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | |||
| 14.74946 % | 4,693,421 | ||
| paragraph, line 2 | Instruments - FITA Ch. 4, section 2, first | ||
| first paragraph, line 3 | Instruments - FITA Ch. 4, section 2, | ||
| - Physically settled | |||
| - Cash settled | |||
| Total | 14.74946 % | 4,693,421 | |
| Chain of |
controlling | companies | |
| Voting rights % Voting rights Company | |||
| 11.09848 | 11.09848 | Bioinvest ApS | |
| 3.65098 | 3.65098 | Goodwind Holding GmbH | |
| Group total |
holdings | ||
| Voting rights | 14.74946 | ||
| Percentage of voting rights 14.74946 | |||
| Published | |||
| 19/06/2023 16:17 |

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from SynAct Pharma
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Board/Management Information
2026
Apr 23
Governance Information
2026
Apr 23
Annual Report
2026
Apr 15
Major Shareholding Notification
2026
Apr 7
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 2